Login

TAY TWO CO., LTD., based in West Japan, is a comprehensive second-hand retail company focused on reselling pre-owned goods. 00:10:00

Share On Facebook Share On Twitter

Yasuyoshi Mitsumoto is Board Member at Tay Two Co Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Avoiding Investment Mistakes: Insights from Allodium Investment Consultants
00:10:00
Ho Kuen Loon, Group CEO, and Ng Chong Jin, Group General Counsel of Fullerton Health, discuss their award-winning project and outline future plans for the company.
00:10:00
venture capital firm and the premiere investor in developer first startups|Joe Ruscio,General Partner,Heavybit
00:10:00
Innovative Entrepreneurs who want to Change the World|Adam Struck, Managing Partner,Struck Capital
00:10:00
Changing the faces of entrepreneurship|Gabby Cazeau,Principal,Harlem Capital Partners
00:10:00
Uranium's Bright Future: Insights from Elevate Uranium's CEO Murray Hill
00:10:00
Morgans adviser Chris Titley recently chatted with Alex Waislitz, founder and Chairman of Thorney Technologies Ltd, about Skyfii Limited.
00:10:00
Raised six major investment funds, including a $1 billion fund aimed at supporting companies|Kirsten Green, founder and Managing Partner, Forerunner Ventures
00:10:00
Exploring Depths: A Conversation with Mark Heine, CEO of FUGRO | Mark Heine - Chief Executive Officer of Fugro
00:10:00
Behind the Scenes: American Century's Impact and the Tahoe Tournament | Jonathan Thomas, CEO , American Century Investments.
00:10:00
Advancements in Genetic Testing and Tumor Profiling for Uveal Melanoma Management |Derek J Maetzold, CEO, Castle Biosciences Inc.
00:10:00
CloudCall CEO says half year results show 'key metrics at the top of our scales' | Simon Cleaver, CEO, Cloudcall Group PLCCLLLF:PNK

© 2017 - Neuhu+